Pain Clinical Trial
Official title:
Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol
Verified date | May 2017 |
Source | Vastra Gotaland Region |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This pilot study will try to minimize the pain during exposure to a new red light source
(RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without
compromising its effect on AKs.
The study design will have an open and prospective, two-armed, split-face design.
Participants with AK lesions distributed symmetrically on the scalp, forehead, cheeks,
torso, back, arms and/or dorsal parts of the hands are eligible for inclusion. The purpose
is to investigate if a modified irradiation protocol can lower the pain while having the
same effect on AK clearance rates as compared to the standard PDT irradiation protocol.
Before any study-related procedures are performed, the participants will be thoroughly
informed about the study and will be given the opportunity to ask questions. The
participants will thereafter sign and date the informed consent form. This constitutes as
visit 0.
On visit 1, a randomization to either the standard or the modified irradiation protocol will
be performed on one side of the face/body and the other irradiation protocol will then be
applied on the other side of the face/body. The participants should have AKs on two
comparable sites, i.e. two cheeks, arms or dorsal parts of the hands. One side will be
randomized to receive PDT with BF200-ALA and irradiation with the RhodoLED® lamp and the
other side will receive BF200-ALA and the Aktilite CL-128 lamp (PhotoCure ASA, Oslo,
Norway), which is the traditional lamp used at our department as mentioned above.
The treatment will be given at visit 1. During the treatment, the participants will be asked
continuously, every third minute, to estimate the pain on each treatment side using the
visual analogue scale, VAS, (where 0 is no pain and 10 is the worst pain imaginable). At the
end of the treatment, the participants will also be asked to summarize the treatment as a
whole on the VAS-scale. After visit 1, the participants will fill in a follow-up diary form
with questions regarding adverse effects (AEs) during the hours and days after the
treatment. The efficacy of the treatment will also be assessed at a follow-up (FU) visit,
visit 2. The investigators are aiming for a non-inferior analysis, i.e. the new modified
irradiation protocol should be at least as good as the standard irradiation protocol. The
randomization is blinded for the investigator at the FU visit to minimize the possibility of
favoring one irradiation protocol.
Status | Completed |
Enrollment | 30 |
Est. completion date | March 2017 |
Est. primary completion date | March 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients with symmetrically distributed AKs on the scalp, forehead, cheeks, torso, back, arms and/or dorsal parts of the hands. - Patients >18 years of age who have signed a written informed consent. Exclusion Criteria: - Pregnant or breast-feeding. - Participating in other clinical study at the same time or within 30 days. - Conditions associated with poor protocol compliance, e.g. excessive use of alcohol or drug abuse. |
Country | Name | City | State |
---|---|---|---|
Sweden | Dep. of Dermatology, Sahlgrenska University Hospital | Gothenburg |
Lead Sponsor | Collaborator |
---|---|
Vastra Gotaland Region |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain assessment | Pain is assessed on a visual analog scale from 0 to 10 (0=no pain at all, 10=worst pain imaginable). The patient assesses the pain during and after the illumination phase of PDT on both treatment sides. | Directly after PDT | |
Secondary | Effectiveness of PDT with the RhodoLED lamp | The effectiveness of PDT on both treatment sides will be compared at follow-up after 3 months. The clinical clearance of AK lesions will be measured. | 3 months after treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|